CONMED Corp Files 8-K on Financials
Ticker: CNMD · Form: 8-K · Filed: Apr 24, 2024 · CIK: 816956
Sentiment: neutral
Topics: financial-reporting, 8-K, operations
Related Tickers: CNMD
TL;DR
CONMED filed its 8-K, check the financials.
AI Summary
CONMED Corporation filed an 8-K on April 24, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the company's performance. CONMED Corporation is incorporated in Delaware and headquartered in Largo, Florida.
Why It Matters
This filing provides crucial updates on CONMED Corporation's financial performance and operational results, which can influence investor decisions and market perception.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not indicate any unusual risks or events.
Key Players & Entities
- CONMED Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Largo, Florida (location) — Principal executive offices
- April 24, 2024 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing for CONMED Corporation?
The primary purpose is to report on CONMED Corporation's results of operations and financial condition, including financial statements and exhibits.
When was this 8-K filing submitted?
The filing was submitted on April 24, 2024.
Where is CONMED Corporation's principal executive office located?
CONMED Corporation's principal executive office is located at 11311 Concept Blvd, Largo, Florida 33773.
What is CONMED Corporation's state of incorporation?
CONMED Corporation is incorporated in Delaware.
What is the SIC code for CONMED Corporation?
The Standard Industrial Classification (SIC) code for CONMED Corporation is 3845, which corresponds to ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
Filing Stats: 498 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-04-24 16:06:48
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value CNMD NYSE Indicate by che
Filing Documents
- form8k-32144_cnmd.htm (8-K) — 25KB
- ex99-1.htm (EX-99.1) — 186KB
- image_001.jpg (GRAPHIC) — 4KB
- 0001174947-24-000582.txt ( ) — 397KB
- cnmd-20240424.xsd (EX-101.SCH) — 3KB
- cnmd-20240424_lab.xml (EX-101.LAB) — 33KB
- cnmd-20240424_pre.xml (EX-101.PRE) — 22KB
- form8k-32144_cnmd_htm.xml (XML) — 3KB
02
Item 2.02 Results of Operations and Financial Condition. On April 24, 2024, CONMED Corporation issued a press release announcing financial results for the first quarter ended March 31, 2024. A copy of this press release is attached hereto as Exhibit 99.1. The information in this Current Report on Form 8-K that is furnished under "Item 2.02. Results of Operations and Financial Condition" and Exhibit 99.1 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Act of 1934, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits The following exhibits are included herewith: Exhibit No. Description of Exhibit 99.1 Press Release dated April 24, 2024, issued by CONMED Corporation. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: April 24, 2024 CONMED CORPORATION (Registrant) By: /s/ Todd W. Garner Name: Todd W. Garner Title: Executive Vice President, Finance & Chief Financial Officer